JPRN-jRCT2080221563未知3 期
Confirmatory study of HFT-290 in patients with chronic pain
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with persistent chronic pain for 12 weeks or longer before obtaining informed consent.
排除标准
- •- Patients with abnormalities at the application site.
- •- Patient with serious cardiac, hepatic, or renal dysfunction, serious respiratory disorders, serious respiratory depression, and other serious complications.
- •- Patients undergoing elective surgery that may have an effect on evaluation of pain.
研究者
相似试验
未知
3 期
ong-term phase III study in patients with chronic pain.Chronic painJPRN-jRCT2080221311Hisamitsu Pharmaceutical Co., Inc.
未知
3 期
A phase III clinical study of HFT-290.Cancer painJPRN-jRCT2080223308Hisamitsu Pharmaceutical Co.,Inc.
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
进行中（未招募）
2 期
A phase II study of S-005151 in patients with chronic liver diseaseChronic liver disease - Liver cirrhosis (alcoholic, non-alcoholic, HBV, or HCV)D008103JPRN-jRCT2031200232Terai Shuji10
招募中
不适用
Efficacy and safety of CH-001 in patients with chronic hepatitis C or NAFLD/NASH (placebo comparative study)JPRN-UMIN000006928Kyoundo Hospital40